North American Indapamide Market Size, Share, Analysis, Industry Report and Forecast 2020-2026
North American indapamide market is estimated to grow significantly at a CAGR of around 0.3% during the forecast period. The market is mainly growing due to the rising prevalence of hypertension and CVD such as heart strokes, blood pressure, arrhythmias among others. According to the Heart & Stroke Foundation in Canada (2017), 1.6 million fatalities occur every year due to stroke and at least 1.3 million Canadians live with heart disease. Further, the population is also more inclined to the risk of heart strokes. According to WHO, the incidence and prevalence rate of heart attacks are the highest in North America, which is responsible for 700,000 fatalities each year. Moreover, the rate of adoption of advanced techniques is the highest in North America which in turn supports the growth of the market in North America.
To Request a Sample of our Report on North American Indapamide Market: https://www.omrglobal.com/request-sample/north-american-indapamide-market
The North American indapamide market is segmented on the basis of
product and application. Based on product, the market is bifurcated into 1.25
mg and 2.5 mg. Among these, the market for 1.25 mg medicine held the
significant market share owing to the extensive application of the drug in
treating high blood pressure or hypertension. Based on the application, the
market is segmented into high blood pressure, heart failure, and others. The
high blood pressure segment is projected to have significant share in the
market. Growing incidence of hypertension is contributing to market growth as
indapamide drugs are significantly used to treat hypertension while reducing
the risk of developing serious heart conditions.
(Get 15% Discount on Buying this Report)
A
full Report of North American Indapamide Market is Available at: https://www.omrglobal.com/industry-reports/north-american-indapamide-market
·
1.25 MG
·
2.5 MG
By
Application
·
High
Blood Pressure
·
Heart
Failure
·
Others
North America
·
United States
·
Canada
Company Profiles
·
ANI
Pharmaceuticals, Inc.
·
Apotex
Inc.
·
Glenmark
Pharmaceuticals Ltd.
·
Krka
Group
·
Mylan
N.V.
·
Preferred
Pharmaceuticals, Inc.
·
Sanis
Health Inc.
·
Sanofi
S.A.
·
Teva
Pharmaceuticals Industries Ltd.
·
Servier
Group
Reasons to Buy From us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-indapamide-market
About Orion
Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment